Jaundice in Newborn

For many mothers-to-be, personal style quickly falls to the wayside during pregnancy, not always for lack of effort but to simply make it through the woes of the first trimester at the very least. But rather than default to your sweats in cold weather, stylish winter maternity dresses abound this season, whether you're in your first, second, or third trimester. Of course, there's no shame in wearing whatever you feel most comfortable in—after all, nurturing yourself is most important when you're growing life inside. But for moments when you're inspired to level up from loungewear, cold-weather-ready sweaterdresses, long-sleeve silhouettes, turtlenecks, maxi-length styles, and more feel equally effortless as that coordinating sweatsuit with an infinitely more polished look. If you're not sure where to look for stylish maternity dresses for winter, there are, of course, pregnancy-specific brands that cater to a growing bump. But they're not the only ones with grea

Most newborn babies turn at least a little bit yellow. Known as jaundice, this condition is a very common and usually normal part of the newborn period. But in some very rare cases it can lead to (or be a sign of) a more serious problem. That's why parents need to know about it. What causes jaundice? The yellow color of newborn jaundice is caused by high levels of a substance called bilirubin in the blood. Bilirubin mostly comes from the breakdown of red blood cells. It gets processed in the liver to make it easier for the body to get rid of through the urine and stool. Newborn livers need some time to get up and running when it comes to getting rid of bilirubin. Newborns also have more red cells than older children and adults, and those brand-new red cells don't last as long as the ones that get made as babies grow older. The combination of these two factors is what makes jaundice so common. Jaundice usually peaks in the first two to five days of life, an

The recent report on " Baby Pram and Stroller Market Report 2021 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2028" offered by Credible Markets , comprises of a comprehensive investigation into the geographical landscape, industry size along with the revenue estimation of the business. Additionally, the report also highlights the challenges impeding market growth and expansion strategies employed by leading companies in the " Baby Pram and Stroller Market ". Key Benefits for Stakeholders The report provides a quantitative analysis of the current Baby Pram and Stroller market trends, estimations, and dynamics of the market size from 2015 to 2028 to identify the prevailing opportunities. Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier–buyer network. In-depth analysis and the market size and segmentation

Figure 4 Kaplan-Meier survival curves demonstrating all cats with S-CCHS (A; n = 162; 6 lost to follow-up), significantly longer survival in S-CCHS cats with cholelithiasis compared to those without cholelithiasis (B), significantly longer survival in S-CCHS cats undergoing cholecystectomy compared with those without cholecystectomy (C), significantly longer survival in S-CCHS cats with cholelithiasis undergoing cholecystectomy compared with those with cholelithiasis not undergoing cholecystectomy (D), significantly longer survival in cats without leukocytosis compared with cats with leukocytosis (E), significantly shorter survival in cats with a ≥ 2-fold increase in ALP activity compared with cats with a < 2-fold increase in ALP activity (F), and significantly longer long-term survival in cats without hyperbilirubinemia compared with cats with hyperbilirubinemia (G). Citation: Journal of the American Veterinary Medical Association 2021; 10.2460/javma.20.10.0555

A small box glowing with a brilliant blue light has saved the lives of numerous babies since its inception, and it's only getting started. This innovative box is called Crib A'Glow, and it's a low-cost phototherapy solution for treating newborn babies with neonatal jaundice, a condition in which a baby's skin and the whites of the eyes appear yellow due to excess bilirubin. When untreated, this ailment, which is extremely common as newborns haven't developed the liver function to properly process the bilirubin, can cause hearing loss, blindness, brain damage, and even death, which is why instant treatment is recommended. This is where the novel phototherapy unit comes in. Saving tiny hearts thanks to technology Crib A'Glow was developed by Virtue Oboro, a mother and graphic designer from Nigeria, after her son's experience with jaundice. Shortly after giving birth in 2015, Oboro noticed the classic yellow hue commonly associated wi

Research by the Oregon State University College of Engineering has led to a promising potential therapy for neonatal jaundice that's more safe, simple and convenient than the blood transfusions currently given to babies suffering from the most dangerous forms of the condition. The study led by Adam Higgins, associate professor of bioengineering, suggests microfluidics and high-intensity light can correct a dangerous bloodstream buildup of bilirubin. Bilirubin is the pigment that's responsible for the yellow skin color associated with jaundice and, at high enough levels, puts the afflicted infant at risk of sometimes irreversible neurological damage or even death. Findings were published in Biomicrofluidics . Neonatal jaundice is a common condition among newborns, whose bodies are busy breaking down the red blood cells used in the uterus and making new ones as the infant transitions to breathing ambient air once outside the womb. Blood's red color stems from a protei

VBI Vaccines has toiled a while to earn its first FDA approval. But for the Massachusetts-based company, the timing may be perfect. In gaining a green light for its hepatitis B shot, VBI is poised to take advantage of what figures to be a growing market. A month ago, a CDC advisory committee voted unanimously to strengthen its recommendation for hepatitis B vaccination, saying that those aged 19 to 59 "should" receive shots. The current guidance for adults is that they "may" get the vaccine and only those deemed at risk "should" receive it. With the FDA blessing, PreHevbrio joins three other hepatitis B shots on the market—Dynavax's Heplisav-B, GlaxoSmithKline's Engerix-B and Merck's Recombivax HB. Already approved in Israel, PreHevbrio is differentiated from the others as a three-antigen vaccine. In a head-to-head phase 3 trial, PreHevbrio provided higher seroprotection than the monovalent Engerix-B. "The feedback we're gett

So your friend/sibling/neighbor just had a baby, or is having a baby soon. Huzzah! Now you're trying to figure out what to get them for the holidays … and, well, it can get a bit overwhelming. There's so much stuff for babies and new parents, all marketed in a way that makes it all seem absolutely crucial . It is, of course, mostly not. For this gift guide, I tried to focus on stuff that is truly useful, doesn't exist solely to freak new parents out and is tough enough to last multiple years/kids. Step one? Ask the parents what they need — everyone's situation is different, and they'll absolutely know best. If they're running short on ideas, though, here are some things they'll probably really appreciate. This article contains links to affiliate partners where available. When you buy through these links, TechCrunch may earn an affiliate commission. Need more gift ideas? Find our other gift guides right here. AirTags Image Credits: Matthew Panza

Among all the different types of cancer treatment, photodynamic therapy – where light is used to destroy malignant cells – might have one of the strangest side effects: Patients are often better able to see in the dark. Last year, researchers finally figured out why this happens: Rhodopsin, a light-sensitive protein in the retinas in our eyes, interacts with a photosensitive compound called chlorin e6, a crucial component of this type of cancer treatment. The work built on what scientists already knew about the organic compound retinal, which is found in the eye and usually isn't sensitive to infrared light.  Visible light triggers retinal to separate from rhodopsin – this is converted into the electrical signal our brains interpret to see. While we don't get much visible light at night, it turns out this mechanism can also be triggered with another combination of light and chemistry. Under infrared light and with a chlori